Preclinical Imaging Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Spread the love

Preclinical imaging refers to the techniques used to visualize and study biological processes in animal models before being applied to human clinical trials. These imaging techniques allow researchers to track disease progression, evaluate the efficacy and safety of potential therapeutics, and gain insights into the biological mechanisms underlying diseases.

Sizing and Forecast
The preclinical imaging market size has grown strongly in recent years. It will grow from $3.2 billion in 2023 to $3.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%.  The  growth in the historic period can be attributed to government initiatives, growing prevalence of diseases, expanding applications, increasing awareness, emerging markets expansion.

The preclinical imaging market size is expected to see strong growth in the next few years. It will grow to $4.42 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.  The growth in the forecast period can be attributed to personalized medicine adoption, advancements in molecular imaging, drug development outsourcing, regulatory support, rising chronic diseases. Major trends in the forecast period include green imaging technologies, technological advancements, rise in r&d activities, collaborations and partnerships, real-time imaging.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Segmentation & Regional Insights
The preclinical imaging market covered in this report is segmented –
1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User

North America was the largest region in the preclinical imaging market in 2023. The regions covered in the preclinical imaging  market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

Major Driver Impacting Market Growth
The increase in chronic diseases is expected to propel the growth of the preclinical imaging market going forward. Chronic diseases refer to long-term health conditions that persist for an extended period, typically lasting for three months or more. These diseases often require ongoing medical management and can significantly impact a person’s quality of life. For identifying chronic diseases, preclinical imaging tools are used for visualizing the bone structure and lung function. It is also used to study chronic diseases to visualize the progression of the disease and improve disease understanding. For instance, in September 2022, according to the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, there were 41 million deaths, which is 74% of all deaths caused by Noncommunicable diseases (NCDs) or chronic diseases every year globally. Among them are 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, increasing chronic disease is driving the growth of the preclinical imaging market.

Key Industry Players
Major companies operating in the preclinical imaging  market report are Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, EKF Diagnostics Holdings plc., Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

The preclinical imaging market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →